| I. |
AMENDMENTS
|
| 1. |
The following definitions in Article 2 shall be inserted as follows:
|
| 2. |
Section 7.5.3.2.1.3 shall be amended and replaced in its entirety as follows:
|
| 7.5.3.2.1.3 |
ASES shall reimburse the Contractor the corresponding COVID-19 vaccine administration fee, administered by qualifying providers and according to Normative Letter 20-1214. For vaccines administered in pharmacies, ASES shall reimburse
Contractor for administration at authorized pharmacies until March 31, 2021.
|
| 3. |
Section 7.5.12.1.2 shall be amended and replaced in its entirety as follows:
|
| 7.5.12.1.2 |
Drugs on the Formulary of Medications Covered (FMC); hormones included may be used by transgender persons for transition therapy.
|
| 4. |
Section 7.7.11.9 shall be amended and replaced in its entirety as follows:
|
| 7.7.11.9 |
The following procedures and diagnostic tests, when Medically Necessary (Prior Authorization required):
|
|
7.7.11.9.1
|
Computerized Tomography;
|
|
7.7.11.9.2
|
Magnetic resonance test;
|
|
7.7.11.9.3
|
Cardiac catheters;
|
|
7.7.11.9.7
|
Lithotripsy;
|
|
7.7.11.9.8
|
Electromyography;
|
|
7.7.11.9.9
|
Single-photon Emission Computed Topography (“SPECT”) test;
|
|
7.7.11.9.10
|
Orthopantogram (“OPG”) test;
|
|
7.7.11.9.11
|
Impedance Plesthymography;
|
| 7.7.11.9.12 |
Other neurological, cerebrovascular, and cardiovascular procedures, invasive and noninvasive;
|
|
7.7.11.9.13
|
Nuclear imaging;
|
|
7.7.11.9.14
|
Diagnostic endoscopies; and
|
|
7.7.11.9.15
|
Genetic studies;
|
| 5. |
Section 7.9.3.8 shall be amended and replaced in its entirety as follows:
|
| 7.9.3.8 |
The Contractor shall ensure at a minimum fifty percent (50%) compliance during the first Contract year, sixty percent (60%) compliance during the second Contract year, and seventy-five percent (75%) compliance during the third and fourth
Contract year, with the EPSDT screening requirements, including blood screening for lead and annual dental examinations and services, using the methodology prescribed by CMS to determine the screening rate. ASES may impose penalties,
sanctions, and/or fines under Articles 19 and 20 if the Contractor fails to comply with the minimum requirements.
|
| 6. |
Section 10.3.2.1.7 shall be amended and replaced in its entirety as follows:
|
| 10.3.2.1.7 |
Require PMGs reimbursed by Contractor under a Subcapitated Arrangement to certify that the PMG has passed through any increase of Subcapitated amounts to its affiliated physicians not organized under a wage compensation model (staff
model). For physicians under a staff model, pass through may be through actions separate from the agreed salary and/or salary scales used by the PMGs to compensate their medical providers. These actions may include, without limitation:
bonuses, payment of professional/continued education courses, payment of licenses, or any other payment or benefit arrangement to incentivize the hired or staff medical providers. None of the foregoing prevents the PMGs with wage compensation
or staff model arrangements with its providers to allow salary increases to its hired medical staff should an individual PMG decide to do so. ASES and Contractor shall track any complaints filed by PMG-affiliated physicians and conduct the
appropriate investigation and diligence to ensure compliance with this section. The Contractor shall provide to ASES an attestation to certify compliance with this section. If PMGs refuse to certify the pass-through of the increase of
Subcapitated amounts to its affiliated physicians, or otherwise fail to comply with this section’s requirements, Contractor may escalate the issue to ASES and shall not be obligated to remit to impacted PMGs the increased amounts set forth
under Section 10.5.1.5.3 until ASES has resolved the issue.
|
| 7. |
The following amended attachments, copies of which are included, are substituted in this Contract as follows:
|
| ATTACHMENT 7: |
UNIFORM GUIDE FOR SPECIAL COVERAGE
|
| ATTACHMENT 9: |
INFORMATON SYSTEMS
|
| ATTACHMENT 12: |
DELIVERABLES AND REPORTING GUIDE
|
| ATTACHMENT 11: |
PER MEMBER PER MONTH PAYMENTS
|
| ATTACHMENT 19: |
HEALTH CARE IMPROVEMENT PROGRAM (HCIP) MANUAL
|
| ATTACHMENT 29: |
MATERNITY KICK PAYMENT METHODOLOGY
|
| ATTACHMENT 31: |
ENROLLEES QUALIFIED FOR THE GOVERNMENT HEALTH PLAN UNDER TEMPORARY EXPANSIONS OF MEDICAID COVERAGE ELIGIBILITY
|
| II. |
RATIFICATION
|
|
III.
|
EFFECT; CMS and FOMB APPROVAL
|
|
IV.
|
AMENDMENT EFFECTIVE DATE
|
|
V.
|
ENTIRE AGREEMENT
|
|
/s/ Jorge E, Galva Rodríguez
|
09/09/2021
|
|
|
Name: Jorge E, Galva Rodríguez, JD, MHA
|
Date
|
|
|
EIN: 66-05000678
|
|
TRIPLE-S SALUD, INC.
|
||
|
/s/ Madeline Hernández Urquiza
|
09/09/2021
|
|
|
Ms. Madeline Hernández Urquiza, President
|
Date
|
|
|
EIN: 66-0555677
|
|
Administración de Seguros de Salud
July 1, 2020 to September 30, 2021
GHP (Vital) PMPM Premium Rates
|
||||
| Rate Cell |
PMPM
|
|||
|
Medicaid Pulmonary
|
$
|
231.19
|
||
|
Medicaid Diabetes or Low Cardio
|
$
|
386.20
|
||
|
Medicaid High Cardio
|
$
|
784.62
|
||
|
Medicaid Renal
|
$
|
1,343.63
|
||
|
Medicaid Cancer
|
$
|
2,564.67
|
||
|
Medicaid Male 45+
|
$
|
147.96
|
||
|
Medicaid Male 19-44
|
$
|
96.78
|
||
|
Medicaid Male 14-18
|
$
|
83.72
|
||
|
Medicaid Female 45+
|
$
|
194.72
|
||
|
Medicaid Female 19-44
|
$
|
130.35
|
||
|
Medicaid Female 14-18
|
$
|
88.82
|
||
|
Medicaid Age 7-13
|
$
|
76.49
|
||
|
Medicaid Age 1-6
|
$
|
112.52
|
||
|
Medicaid Under 1
|
$
|
304.22
|
||
|
Public EE Commonwealth Pulmonary
|
$
|
184.28
|
||
|
Public EE Commonwealth Diabetes or Low Cardio
|
$
|
233.91
|
||
|
Public EE Commonwealth High Cardio
|
$
|
441.73
|
||
|
Public EE Commonwealth Renal
|
$
|
652.83
|
||
|
Public EE Commonwealth Cancer
|
$
|
1,520.12
|
||
|
Public EE Commonwealth Male 45+
|
$
|
101.96
|
||
|
Public EE Commonwealth Male 19-44
|
$
|
64.70
|
||
|
Public EE Commonwealth Male 14-18
|
$
|
77.11
|
||
|
Public EE Commonwealth Female 45+
|
$
|
136.74
|
||
|
Public EE Commonwealth Female 19-44
|
$
|
102.63
|
||
|
Public EE Commonwealth Female 14-18
|
$
|
81.01
|
||
|
Public EE Commonwealth Age 7-13
|
$
|
77.89
|
||
|
Public EE Commonwealth Age 1-6
|
$
|
108.10
|
||
|
Public EE Commonwealth Under 1
|
$
|
372.99
|
||
|
CHIP Pulmonary
|
$
|
253.23
|
||
|
CHIP Diabetes
|
$
|
1,042.92
|
||
|
CHIP Age 7-13
|
$
|
87.49
|
||
|
CHIP Age 14+
|
$
|
97.03
|
||
|
CHIP Age 1-6
|
$
|
126.60
|
||
|
CHIP Under 1
|
$
|
302.89
|
||
|
Dual Eligible Part A and B
|
$
|
359.73
|
||
|
Dual Eligible Part A Only
|
$
|
393.32
|
||
|
Commonwealth to Medicaid Pulmonary
|
$
|
197.39
|
||
|
Commonwealth to Medicaid Diabetes or Low Cardio
|
$
|
254.35
|
||
|
Commonwealth to Medicaid High Cardio
|
$
|
472.17
|
||
|
Commonwealth to Medicaid Renal
|
$
|
695.20
|
||
|
Commonwealth to Medicaid Cancer
|
$
|
1,571.43
|
||

|
|
|
Commonwealth to Medicaid Male 45+
|
$
|
108.42
|
||
|
Commonwealth to Medicaid Male 19-44
|
$
|
69.37
|
||
|
Commonwealth to Medicaid Male 14-18
|
$ | 80.71 |
||
|
Commonwealth to Medicaid Female 45+
|
$
|
147.38
|
||
|
Commonwealth to Medicaid Female 19-44
|
$
|
109.17
|
||
|
Commonwealth to Medicaid Female 14-18
|
$
|
83.99
|
||
|
Commonwealth to Medicaid Age 7-13
|
$
|
81.92
|
||
|
Commonwealth to Medicaid Age 1-6
|
$
|
111.61
|
||
|
Commonwealth to Medicaid Under 1
|
$
|
379.93
|
||
|
PRPL Medicaid Male 45+
|
$
|
387.51
|
||
|
PRPL Medicaid Male 19-44
|
$
|
170.63
|
||
|
PRPL Medicaid Male 14-18
|
$
|
121.99
|
||
|
PRPL Medicaid Female 45+
|
$
|
451.41
|
||
|
PRPL Medicaid Female 19-44
|
$
|
222.00
|
||
|
PRPL Medicaid Female 14-18
|
$
|
143.11
|
||
|
PRPL Medicaid Age 7-13
|
$
|
117.69
|
||
|
PRPL Medicaid Age 1-6
|
$
|
173.24
|
||
|
PRPL Medicaid Under 1
|
$
|
354.64
|
||
|
PRPL CHIP Age 7-13
|
$
|
122.71
|
||
|
PRPL CHIP Age 14+
|
$
|
145.26
|
||
|
PRPL CHIP Age 1-6
|
$
|
183.62
|
||
|
PRPL CHIP Under 1
|
$
|
319.92
|
||
|
Transferred to CHIP Under 1
|
$
|
302.89
|
||
|
Transferred to CHIP Age 1-6
|
$
|
126.60
|
||
|
Transferred to CHIP Age 7-13
|
$
|
87.49
|
||
|
Transferred to CHIP Age 14+
|
$
|
97.03
|
||
|
Transferred to CHIP Diabetes
|
$
|
1,042.92
|
||
|
Transferred to CHIP Pulmonary
|
$
|
253.23
|
||
|
Maternity Kick Payment
|
$
|
5,370.02
|

|
|